300158.SZ · 振东制药
China A-shares · RS rating 50 · As of 2026-10-14
| Price | 5.09 CNY |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 53 / 68 / 24 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 12 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +30.9% |
| Market cap (USD) | $788.0M |